You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API azelastine hydrochloride and fluticasone propionate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing azelastine hydrochloride and fluticasone propionate

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Meda Pharmaceuticals Inc	DYMISTA	azelastine hydrochloride and fluticasone propionate	0037-0245	BENZALKONIUM CHLORIDE
Meda Pharmaceuticals Inc	DYMISTA	azelastine hydrochloride and fluticasone propionate	0037-0245	CARBOXYMETHYLCELLULOSE SODIUM
Meda Pharmaceuticals Inc	DYMISTA	azelastine hydrochloride and fluticasone propionate	0037-0245	CELLULOSE, MICROCRYSTALLINE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for azelastine hydrochloride and fluticasone propionate

Excipient focus: BENZALKONIUM CHLORIDE

azelastine hydrochloride and fluticasone propionate drug variants containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Meda Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0037-0245
Mylan Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0378-3458
>Company	>Ingredient	>NDC

azelastine hydrochloride and fluticasone propionate drug variants not containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

azelastine hydrochloride and fluticasone propionate drug variants containing CARBOXYMETHYLCELLULOSE SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Meda Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0037-0245
Mylan Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0378-3458
>Company	>Ingredient	>NDC

azelastine hydrochloride and fluticasone propionate drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CELLULOSE, MICROCRYSTALLINE

azelastine hydrochloride and fluticasone propionate drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Meda Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0037-0245
Mylan Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0378-3458
>Company	>Ingredient	>NDC

azelastine hydrochloride and fluticasone propionate drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: EDETATE DISODIUM

azelastine hydrochloride and fluticasone propionate drug variants containing EDETATE DISODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Meda Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0037-0245
Mylan Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0378-3458
>Company	>Ingredient	>NDC

azelastine hydrochloride and fluticasone propionate drug variants not containing EDETATE DISODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GLYCERIN

azelastine hydrochloride and fluticasone propionate drug variants containing GLYCERIN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Meda Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0037-0245
Mylan Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0378-3458
>Company	>Ingredient	>NDC

azelastine hydrochloride and fluticasone propionate drug variants not containing GLYCERIN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PHENYLETHYL ALCOHOL

azelastine hydrochloride and fluticasone propionate drug variants containing PHENYLETHYL ALCOHOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Meda Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0037-0245
Mylan Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0378-3458
>Company	>Ingredient	>NDC

azelastine hydrochloride and fluticasone propionate drug variants not containing PHENYLETHYL ALCOHOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 80

azelastine hydrochloride and fluticasone propionate drug variants containing POLYSORBATE 80

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Meda Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0037-0245
Mylan Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0378-3458
>Company	>Ingredient	>NDC

azelastine hydrochloride and fluticasone propionate drug variants not containing POLYSORBATE 80

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

azelastine hydrochloride and fluticasone propionate drug variants containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Meda Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0037-0245
Mylan Pharmaceuticals Inc	azelastine hydrochloride and fluticasone propionate	0378-3458
>Company	>Ingredient	>NDC

azelastine hydrochloride and fluticasone propionate drug variants not containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.